Disclosed herein is a newly isolated human coronavirus (SARS-CoV), the causative agent of severe acute respiratory syndrome (SARS). Also provided are the nucleic acid sequence of the SARS-CoV genome and the amino acid sequences of the SARS-CoV open reading frames, as well as methods of using these molecules to detect a SARS-CoV and detect infections therewith. Immune stimulatory compositions are also provided, along with methods of their use.
From the Reiner/Martin interview:
Coronavirus as a circulating pathogen inside of the viral model that we have is actually not new to the human condition and is not new to the last two decades. It’s actually been part of the sequence of proteins that circulates for quite a long time. But the alleged outbreak that took place in China in 2002, going into 2003 gave rise to a very problematic April 2003 filing by the United States Centre for Disease Control and Prevention. And this topic is of critical importance to get the nuance very precise, because in addition to filing the entire gene sequence on what became SARS Coronavirus, which is actually a violation of 35 US Code Section 101. You cannot patent a naturally occurring substance. The 35 US Code Section 101 violation was patent number 7220852.
— Dr. David Martin at 15:32
According to Dr. David Martin, this is the patent that records the entire gene sequence for the SARS Coronavirus. All other Coronavirus related patents contain a segment of this sequence. According to Dr. Martin, the sequence found for SARS CoV 2 is a segment of the original SARS Coronavirus. This is documented in his report.
Source:
- May 22, 2007. Paul A. Rota, Larry J. Anderson, William J. Bellini, Cara Carthel Burns, Raymond Campagnoli, Qi Chen, James A. Comer, Shannon L. Emery, Dean D. Erdman, Cynthia S. Goldsmith, Charles D. Humphrey, Joseph P. Icenogle, Thomas G. Ksiazek, Stephan S. Monroe, William Allan Nix, M. Steven Oberste, Teresa C. T. Peret, Pierre E. Rollin, Mark A. Pallansch, Anthony Sanchez, Suxiang Tong, and Sherif R. Zaki. United States Patent: 7220852 – Coronavirus isolated from humans. 7220852, filed April 12, 2004, and issued May 22, 2007. Assignee: The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention (Washington, DC).
https://patents.google.com/patent/US7220852B1,
https://patents.justia.com/patent/7220852,
Local copy.
Patent. - July 12, 2021. “Reiner Fuellmich Interviews Dr David Martin – CDC Patent Fraud.” Covid Truths.
https://www.covidtruths.co.uk/2021/07/reiner-fuellmich-interviews-dr-david-martin-cdc-patent-fraud/.
Blog, Video, Expert.
Includes transcript. - April 3, 2020. M•CAM International. “CoV Patent Corpus Literature Review.”
https://www.m-cam.com/wp-content/uploads/2020/04/20200403_SARS_CoV_Patent_Corpus_Lit_Review.pdf.
Expert, PDF.
See also, on this site:
Related:
- “Clade – Definition, Function and Examples.” Biology Dictionary.
https://biologydictionary.net/clade/.
Reference.